Session 9: Cancer Therapy

Sign In to gain access to subscriptions and/or personal tools.

This Article

	Free Full Text (Free PDF) Free
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Alert me to new issues of the journal
	Add to Saved Citations
	Download to citation manager
	Request Permissions
	Request Reprints
	Add to My Marked Citations

Citing Articles

	Citing Articles via Google Scholar
	Citing Articles via Scopus

Google Scholar

	Search for Related Content

Social Bookmarking

	What's this?

References

Okamura, H., Tsutsui, H., Kashiwamura, S., Yoshimoto, T., and Nakanishi, K. (1998). Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv Immunol 70, 281—312.[Web of Science][Medline] [Order article via Infotrieve]

Jonak, Z.L., Trulli, S., Maier, C., McCabe, F., Kirkpatrick, R., Johanson, K., Ho, Y.S., Chen, Y.J., Herzyk, D., Lotze, M.T., and Johnson, R.K. (2002.) High-dose rInterleukin-18 induces an effective Th1 immune response to murine MOPC-315 plasmacytoma. Journal of Immunotherapy 25(Suppl 1), S20—7.[CrossRef]

Nakanishi, K., Yoshimoto, Y., Tsutsui, H., and Okamura, H. (2001). Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19, 423—74.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Akira, S. (2000). The role of IL-18 in innate immunity. Current Opinion in Immunol. 12, 59—63.[CrossRef]

Kreitman, R.J., Wilson, W.H., Bergeron, K., Raggio, M., Stetler-Stevenson, M., FitzGerald, D.J., and Pastan, I. (2001). Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant Hairy cell leukemia. N Engl J Med 345, 241—7.[Abstract/Free Full Text]

Salvatore, G., Beers, R., Margulies, I., Kreitman, R.J., and Pastan, I. (2002). Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phase display. Clin Cancer Res 8, 995—1002.[Abstract/Free Full Text]

Chowdhury, P.S., and Pastan, I. (1999). Improving antibody affinity by mimicking somatic hypermutation in vitro. Nature Biotech. 17, 568—72.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

Kreitman, R.J., Margulies, I., Stetler-Stevenson, M., Wang, Q.C., FitzGerald, D.J.P., and Pastan, I. (2000). Cytotoxic activity of disulfide-stabilized recombinant immunotoxin RFB4(dsFv)-PE38 toward fresh malignant cells from patients with B-cell leukemias. Clin Cancer Res 6, 1476—87.[Abstract/Free Full Text]

Pastan, I. (2003). Immunotoxins containing Pseudomonas exotoxin A: a short history. Symposium in Writing, Reisfeld, R. A. (Ed.): Cancer Immunol Immunother 52, 338—41.